Ark Therapeutics Grp - Total Voting Rights

* Reuters is not responsible for the content in this press release.

Mon Mar 31, 2008 7:39am EDT 

RNS Number:1700R
Ark Therapeutics Group PLC
31 March 2008

31 March 2008



                           Ark Therapeutics Group plc

                           Voting Rights and Capital



In accordance with the FSA's Disclosure and Transparency Rules, Ark Therapeutics
Group plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date of
this announcement the Company's issued share capital consists of 205,141,876
ordinary shares with voting rights.

This figure may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to the interest in, Ark under the FSA's Disclosure and Transparency
Rules.


                                    - Ends -



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TVREAADFDDKPEFE
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.